KeY Treat Program - Kentucky, United States
Virus targets
Hepatitis C
Type
Testing and treatment implementation
Setting
Micro elimination
Other targets
HIV
Phase
Planning
Health outcomes
Incidence
Prevalence
WHO region
Region of the Americas
Country
United States of America
Key interventions
Persons who inject drugs: HCV cure as prevention
Persons who inject drugs: Medication assisted therapy
Persons who inject drugs: Syringe service program(s)
Treatment (direct or referral)
Target population
Adults (> 19 years of age)
Incarcerated populations (current and former)
Persons who inject drugs
Performance target
Care cascade: HCV diagnosis
Care cascade: HCV treatment
Harm reduction (access to safe injection equipment for persons who inject drugs)
Injection safety
Health outcomes additional info
Outcomes focused on: number of participants initiating and completing HCV treatment; SVR and re-infection.
